Nitric Oxide Releasing Solutions to Prevent and Treat Mild/Moderate COVID-19 Infection
Clinical trial NCT04337918 · COMPLETED
Trial details
- NCT number
- NCT04337918
- Sponsor
- Sanotize Research and Development corp.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-08
- Primary completion
- 2021-01-31
- Enrollment
- 143
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.